Economy

Incyte Corporation (INCY) EVP Sells $2800000.00 in Stock

Incyte Corporation (INCY) EVP Sells $2800000.00 in Stock”

The stock's traded 3.15 million shares in session while it holds an average volume of 1.3 million shares. However, the institutional investors are observed to own 96.10% of the total shares. Sumitomo Mitsui Trust Holdings Inc. owned 0.26% of Incyte Corporation worth $68,030,000 as of its most recent SEC filing. As of the end of the quarter Rock Springs Capital Management Lp had bought 4,000 shares growing its position 2.4%. Rhenman & Partners Asset Management Ab now controls 140,046 shares worth $17,633,000. The Company kept a record of 204.69 million floated shares and 206.99 million shares outstanding.

Janus Capital Management LLC reduced its holdings by shedding 241,429 shares a decrease of 62.7% in the quarter. State of Alaska Department of Revenue increased its position in shares of Incyte Corporation by 5.4% in the second quarter. IFP Advisors Inc now owns 1,043 shares of the biopharmaceutical company's stock valued at $139,000 after purchasing an additional 66 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its position in shares of Incyte Corporation by 2.8% in the second quarter.

Verisk Analytics, Inc.is a data analytics well-known provider serving clients in insurance, natural resources and financial services. $172,597 worth of Incyte Corporation (NASDAQ:INCY) was sold by GRYSKA DAVID W. On Friday, May 5 Trower Paul sold $365,100 worth of Incyte Corporation (NASDAQ:INCY) or 3,000 shares. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of USA and worldwide copyright & trademark legislation. Legal & General Group has an ownership of 738,591 stocks of the biopharmaceutical firms shares valued at $98,727,000 after scooping up an extra 76,447 shares through out the quarter. The information was declared in a transaction filed with the SEC which is available through the Security and Exchange Commission website. The disclosure for this sale can be found here. Insiders sold a total of 70,294 shares of company stock worth $9,072,019 in the last three months.

The stock increased 2.21% or $0.37 on September 8, reaching $17.12.

Incyte Corporation (INCY) opened at 134.34 on Friday. The company has market cap of $7.01 billion.

Moreover, Cibc Mkts has 0% invested in Incyte Corporation (NASDAQ:INCY). INCY's latest closing price was 8.07% away from the average-price of 200 days while it maintained a distance of 3.65% from the 50 Day Moving Average and 5.63% away compared to its SMA 20.

Incyte Corporation (NASDAQ:INCY) last announced its earnings results on Tuesday, August 1st. Looking ahead to earnings forecasts, for the running fiscal period, Wall Street analysts have anticipated that the company will report 0.56 earnings per share. The company's net profit margin has achieved the current level of -11.8 percent and possesses 94.3 percent gross margin. The firm had revenue of $326.40 million during the quarter, compared to analyst estimates of $318.45 million. The company's revenue was up 32.5% compared to the same quarter past year. BMO Capital Markets boosted their price target on shares of Incyte Corporation from $144.00 to $146.00 and gave the company an "outperform" rating in a research report on Friday, May 5th.

Among 23 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 3 Hold.

EVP Steven H. Stein let go of 2,111 shares at an average price of $125.00 on August 29th. A statistical measure of the dispersion of returns (volatility) for INCY producing salvation in Investors mouth, it has week volatility of 5.28% and for the month booked as 3.27%. Morgan Stanley reissued an "overweight" rating and issued a $142.00 price objective on shares of Incyte Corporation in a research report on Friday, May 19th. Zacks Investment Research upgraded Incyte Corporation from a "sell" rating to a "hold" rating in a research note on Tuesday, May 23rd. J.P. Morgan maintained it with "Buy" rating and $14900 target in Tuesday, August 1 report. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company's stock. A beta of less than 1 indicates the stock will be less volatile than the market, and correspondingly, a beta of more than 1 indicates the stock's price will be more volatile than the market.

Incyte Corporation, launched on April 8, 1991, is a biopharmaceutical company. Its portfolio includes compounds in various stages, ranging from preclinical to late-stage development, and commercialized products, such as JAKAFI (ruxolitinib) and ICLUSIG (ponatinib).



Like this

Latest


10 September 2017
Investors Buy Kimberly-Clark Corporation (KMB) on Weakness
The New York-based Greenlight Capital Inc has invested 0.48% in the stock. 37 funds opened positions while 87 raised stakes. Tortoise Investment Management LLC grew its stake in shares of Kimberly-Clark Corporation by 4.7% in the first quarter.

10 September 2017
Patterson-UTI Energy, Inc. (PTEN) Stock Rating Reaffirmed by Piper Jaffray Companies
Finally, Capstone Investment Advisors LLC bought a new stake in Patterson-UTI Energy during the second quarter valued at $275,000. The Company owns and operates a fleet of land-based drilling rigs and a fleet of pressure pumping equipment in the United States.

10 September 2017
Rohingyas illegal migrants, need to go: Rijiju
Despite facing a lot of criticism, India has made its position clear on the Rohingya issue. None of them wants to go back to Myanmar, fearing severe reprisal and genocide.

10 September 2017
Shares Trading down at $13.10 (VRX) Valeant To Participate At The Morgan…
It fall, as 82 investors sold VRX shares while 87 reduced holdings. 49 funds opened positions while 82 raised stakes. Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) has declined 48.51% since September 5, 2016 and is downtrending.

10 September 2017
Trump says military action against North Korea is not first choice
After years of incrementally tougher sanctions against North Korea, the United Nations is now weighing additional steps. Ms Haley said on Monday that the United States was seeking a vote on the new sanctions on September 11.

10 September 2017
Ranveer Singh and Karisma Kapoor dancing on 'sarkaye lo khatiya' is hilarious
The talented actor is now shooting for Sanjay Leela Bhansali's epic-drama Padmavati alongside Deepika Padukone and Shahid Kapoor. Trust Ranveer Singh for the unending energy and mad stunts he performs nearly on a daily basis.

10 September 2017
The Seattle Genetics, Inc. (SGEN) Position Cut by Shell Asset Management Co
Northern Trust Corp decreased Dollar Tree Inc (NASDAQ:DLTR) stake by 185,766 shares to 2.60 million valued at $200.56M in 2016Q4. The investment managers in our partner's database now own: 135.77 million shares, down from 137.16 million shares in 2016Q3.

10 September 2017
USA historian who lived in Afghanistan dies at 90
The foundation also ensures the safety of the document collection - which will in turn ensure the Dupree's legacy lives on. Nancy Dupree traveled across Afghanistan and wrote several guidebooks on the country.

10 September 2017
Comcast Corporation (NASDAQ:CMCSA) Trading Volume Significantly Higher
MRC Global Inc.is an industrial distributor of pipe, valves and fittings and related services and products to the energy industry. Patriot Financial Group Insurance Agency LLC raised its position in shares of Comcast Corporation by 100.0% in the 1st quarter.

10 September 2017
$0.55 EPS Expected for Oracle Corporation (ORCL)
With 10.23 million avg volume, 3 days are for Oracle Corporation (NYSE:ORCL)'s short sellers to cover ORCL's short positions. The stock of Oracle Corporation (NYSE:ORCL) earned "Outperform" rating by BMO Capital Markets on Thursday, March 16.



Recommended